A Phase 2 interventional study of chlorexidine in Dental Pulp Necrosis, sponsored by Universidade Federal do Ceara. Status unknown at 1 site in Brazil. Open to participants aged 4 Years to 8 Years. Per ClinicalTrials.gov, last updated 2008-02-27.
Sponsored by Universidade Federal do Ceara · Phase 2, Interventional, and Treatment
The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.
149 studies on the registry are indexed under Dental Pulp Necrosis; 39 are open to participants now.
This study's planned enrollment of 30 is below the median of 44 across 139 interventional studies indexed under Dental Pulp Necrosis.
Browse Dental Pulp Necrosis studies →Universidade Federal do Ceara is the lead sponsor of 21 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Chlorexidine gel 1% during 7 days inside root canals
This study is status unknown, as verified in Feb 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Federal do Ceara